Skip to main content
Equibles
A logo

A · Agilent Technologies, Inc. · Metrics

Track A — free

Use A with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research A.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$173.07 -0.82 (-0.47%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$48.79B
Shares
281.93M
Volume · Oct 23 1.76M Avg daily vol (3M) 2.21M

A metrics

120 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$173.07
Market cap
$48.79B

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
+0.2%
Price change (3M)
+24.9%
Price change (6M)
+49.8%
Price change (YTD)
+27.2%
Price change (1Y)
+17.4%
Trailing year
Price change (5Y)
+9.6%
52-week high
$177.75
52-week low
$110.24
Change from 52-week high
-2.6%
Change from 52-week low
+57.0%
Annualized volatility
32.5%
Annualized volatility (3M)
27.8%
Beta
0.9
RSI (14D)
57.3
Price vs SMA 50
+7.2%
Price vs SMA 200
+27.9%
Avg volume (3M)
2.21M
Relative volume
0.8
Average dollar volume
$350.66M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
281.93M

Valuation

12 metrics
P / E (TTM)
34.1
Trailing earnings · reciprocal yield 2.9%
PEG ratio
4.0
EV / revenue
6.9×
reciprocal yield 14.5%
EV / EBITDA
26.7×
reciprocal yield 3.7%
EV / EBIT
31.1×
reciprocal yield 3.2%
P / sales
6.6×
reciprocal yield 15.1%
P / book
6.6
reciprocal yield 15.1%
FCF yield
2.6%
TTM · current market cap
Buyback yield
0.8%
P / FCF
38.5
reciprocal yield 2.6%
P / operating cash flow
30.3
reciprocal yield 3.3%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
29.8×
reciprocal yield 3.4%
P / E historical average (5Y)
30.3×
reciprocal yield 3.3%
EV / revenue historical average (3Y)
5.8×
reciprocal yield 17.2%
EV / revenue historical average (5Y)
6.1×
reciprocal yield 16.3%
EV / EBIT historical average (3Y)
27.5×
reciprocal yield 3.6%
EV / EBIT historical average (5Y)
28.3×
reciprocal yield 3.5%
EV / EBITDA historical average (3Y)
22.8×
reciprocal yield 4.4%
EV / EBITDA historical average (5Y)
23.2×
reciprocal yield 4.3%

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
19.9%
Shareholder yield
1.4%
Dividend / share (TTM)
$1.02
Dividend growth YoY
+2.8%
Dividend growth streak
0
Last ex-dividend
2026-10-06

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-26

Profitability

9 metrics
Gross margin
53.8%
Operating margin
22.2%
Trailing 12 months
Net margin
19.5%
Gross profit (TTM)
$3.97B
Operating profit (TTM)
$1.64B
Net income (TTM)
$1.44B
Trailing 12 months
Diluted EPS (TTM)
$5.08
FCF margin
17.2%
Effective tax rate
13.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$26.03
Gross profit per diluted share (TTM)
$14.01
Operating profit per diluted share (TTM)
$5.79
EBITDA per diluted share (TTM)
$6.74
Net income per diluted share (TTM)
$5.08
Operating cash flow per diluted share (TTM)
$5.68
Free cash flow per diluted share (TTM)
$4.47
Capital expenditures per diluted share (TTM)
$1.21
R&D per diluted share (TTM)
$1.71
Stock compensation per diluted share (TTM)
$0.46
Book value per share
$23.82

Growth

11 metrics
Revenue growth YoY
+8.1%
Year over year
Net income growth YoY
+7.7%
Revenue (TTM)
$7.37B
Trailing 12 months
EPS growth YoY
+8.5%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.5%
Revenue CAGR (5Y)
+5.4%
EPS CAGR (3Y)
+3.0%
EPS CAGR (5Y)
+14.7%
FCF CAGR (3Y)
+4.1%
FCF CAGR (5Y)
+7.5%

Quality

14 metrics
Return on equity
19.6%
Return on assets
10.3%
Debt / equity
0.5
Current ratio
2.1
EBITDA (TTM)
$1.91B
Free cash flow (TTM)
$1.27B
Quick ratio
1.6
Interest coverage
15.5
Net debt / EBITDA
1.1
Return on invested capital
14.9%
Trailing 12 months
Net cash
−$2.19B
Latest balance sheet
Cash & equivalents
$1.76B
Total assets
$13.97B
Total debt
$3.95B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.61B
Capital expenditures (TTM)
$342.00M
R&D (TTM)
$485.00M
SG&A (TTM)
$1.84B
Stock compensation (TTM)
$131.00M
R&D / revenue
6.6%
Stock compensation / revenue
1.8%

Ownership (13F)

9 metrics
13F filers
1,138
13F filer change QoQ
+58
Institutional ownership
93.6%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
17.7%
Private-fund adviser ownership
16.7%
Active holders' share change QoQ
+0.8%
Holder tenure
18.0
Price vs estimated holder cost
+4.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.0%

Short interest

3 metrics
Short interest
1.9%
Latest settlement · 1.8 days to cover
Days to cover
1.8d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$95,972
Insider-sentiment score
57 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1090872 CUSIP 00846U101 13F (30d) 308 filings 296 filers Visit website Investor relations